BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 35793555)

  • 1.
    Zhang J; Chen H
    J Chem Inf Model; 2022 Jul; 62(14):3291-3306. PubMed ID: 35793555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De Novo Molecule Design Through the Molecular Generative Model Conditioned by 3D Information of Protein Binding Sites.
    Xu M; Ran T; Chen H
    J Chem Inf Model; 2021 Jul; 61(7):3240-3254. PubMed ID: 34197105
    [No Abstract]   [Full Text] [Related]  

  • 3. De novo molecular design with deep molecular generative models for PPI inhibitors.
    Wang J; Chu Y; Mao J; Jeon HN; Jin H; Zeb A; Jang Y; Cho KH; Song T; No KT
    Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35830870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNMG: Deep molecular generative model by fusion of 3D information for de novo drug design.
    Song T; Ren Y; Wang S; Han P; Wang L; Li X; Rodriguez-Patón A
    Methods; 2023 Mar; 211():10-22. PubMed ID: 36764588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based
    Li Y; Pei J; Lai L
    Chem Sci; 2021 Oct; 12(41):13664-13675. PubMed ID: 34760151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From Target to Drug: Generative Modeling for the Multimodal Structure-Based Ligand Design.
    Skalic M; Sabbadin D; Sattarov B; Sciabola S; De Fabritiis G
    Mol Pharm; 2019 Oct; 16(10):4282-4291. PubMed ID: 31437001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep Learning Applied to Ligand-Based De Novo Drug Design.
    Palazzesi F; Pozzan A
    Methods Mol Biol; 2022; 2390():273-299. PubMed ID: 34731474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Training recurrent neural networks as generative neural networks for molecular structures: how does it impact drug discovery?
    D'Souza S; Kv P; Balaji S
    Expert Opin Drug Discov; 2022 Oct; 17(10):1071-1079. PubMed ID: 36216812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generative Deep Learning for Targeted Compound Design.
    Sousa T; Correia J; Pereira V; Rocha M
    J Chem Inf Model; 2021 Nov; 61(11):5343-5361. PubMed ID: 34699719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances and Challenges in De Novo Drug Design Using Three-Dimensional Deep Generative Models.
    Xie W; Wang F; Li Y; Lai L; Pei J
    J Chem Inf Model; 2022 May; 62(10):2269-2279. PubMed ID: 35544331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scaffold-Constrained Molecular Generation.
    Langevin M; Minoux H; Levesque M; Bianciotto M
    J Chem Inf Model; 2020 Dec; 60(12):5637-5646. PubMed ID: 33301333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of structure- and ligand-based scoring functions for deep generative models: a GPCR case study.
    Thomas M; Smith RT; O'Boyle NM; de Graaf C; Bender A
    J Cheminform; 2021 May; 13(1):39. PubMed ID: 33985583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Simple Way to Incorporate Target Structural Information in Molecular Generative Models.
    Zhang W; Zhang K; Huang J
    J Chem Inf Model; 2023 Jun; 63(12):3719-3730. PubMed ID: 37318828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Explore drug-like space with deep generative models.
    Wang J; Mao J; Wang M; Le X; Wang Y
    Methods; 2023 Feb; 210():52-59. PubMed ID: 36682423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cMolGPT: A Conditional Generative Pre-Trained Transformer for Target-Specific De Novo Molecular Generation.
    Wang Y; Zhao H; Sciabola S; Wang W
    Molecules; 2023 May; 28(11):. PubMed ID: 37298906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo design with deep generative models based on 3D similarity scoring.
    Papadopoulos K; Giblin KA; Janet JP; Patronov A; Engkvist O
    Bioorg Med Chem; 2021 Aug; 44():116308. PubMed ID: 34280849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generative Recurrent Networks for De Novo Drug Design.
    Gupta A; Müller AT; Huisman BJH; Fuchs JA; Schneider P; Schneider G
    Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29095571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Hybrid Neural Network Deep Learning Method for Protein-Ligand Binding Affinity Prediction and De Novo Drug Design.
    Limbu S; Dakshanamurthy S
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular substructure tree generative model for de novo drug design.
    Wang S; Song T; Zhang S; Jiang M; Wei Z; Li Z
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35039853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The power of deep learning to ligand-based novel drug discovery.
    Baskin II
    Expert Opin Drug Discov; 2020 Jul; 15(7):755-764. PubMed ID: 32228116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.